We report a novel strategy to construct temperature-responsive nanocarriers for controlled release based on mesoporous silica and reversible single-stranded DNA valves.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: